Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Stoke Therapeutics, Inc. | 10%+ Owner | Common Stock | 8.91M | $125M | $14.05 | Sep 19, 2024 | Indirect |
Akero Therapeutics, Inc. | Former 10% owner | Common Stock | 3.27M | $2.01M | $0.62 | Dec 1, 2022 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
STOK | Stoke Therapeutics, Inc. | Sep 19, 2024 | 1 | -$27.2M | 4 | Sep 23, 2024 | 10%+ Owner |
STOK | Stoke Therapeutics, Inc. | Apr 17, 2024 | 1 | -$41.8M | 4 | Apr 18, 2024 | 10%+ Owner |
AKRO | Akero Therapeutics, Inc. | Dec 1, 2022 | 1 | -$71.2M | 4 | Dec 5, 2022 | Former 10% owner |
AKRO | Akero Therapeutics, Inc. | Jun 21, 2021 | 0 | $0 | 3 | Jun 30, 2021 | 10%+ Owner |
STOK | Stoke Therapeutics, Inc. | Jun 21, 2021 | 0 | $0 | 3 | Jun 30, 2021 | 10%+ Owner |